Bisphosphonate-Associated Osteonecrosis of the Jaw
"Bisphosphonate-Associated Osteonecrosis of the Jaw" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Necrotic jaws or other maxillofacial skeleton necrosis associated with bisphosphonate use (see BISPHOSPHONATES). Injury, dental procedures, and trauma can trigger the necrotic process.
Descriptor ID |
D059266
|
MeSH Number(s) |
C05.116.852.087 C05.500.086 C07.320.086 C23.550.717.732.183
|
Concept/Terms |
Bisphosphonate-Associated Osteonecrosis of the Jaw- Bisphosphonate-Associated Osteonecrosis of the Jaw
- Bisphosphonate Associated Osteonecrosis of the Jaw
- Bisphosphonate-Induced Osteonecrosis of the Jaw
- Bisphosphonate Induced Osteonecrosis of the Jaw
- Bisphosphonate-Induced Osteonecrosis of the Jaws
- Bisphosphonate Induced Osteonecrosis of the Jaws
- Bisphosphonate-Related Osteonecrosis of the Jaw
- Bisphosphonate Related Osteonecrosis of the Jaw
- Osteonecrosis of the Jaws, Bisphosphonate-Associated
- Osteonecrosis of the Jaws, Bisphosphonate Associated
- Osteonecrosis of the Jaw, Bisphosphonate-Related
- Osteonecrosis of the Jaw, Bisphosphonate Related
- Osteonecrosis of the Jaws, Bisphosphonate-Induced
- Osteonecrosis of the Jaws, Bisphosphonate Induced
- Osteonecrosis of the Jaws, Bisphosphonate-Related
- Osteonecrosis of the Jaws, Bisphosphonate Related
- Osteonecrosis of the Jaw, Bisphosphonate-Associated
- Osteonecrosis of the Jaw, Bisphosphonate Associated
- Bisphosphonate-Associated Osteonecrosis of the Jaws
- Bisphosphonate Associated Osteonecrosis of the Jaws
- Osteonecrosis of the Jaw, Bisphosphonate-Induced
- Osteonecrosis of the Jaw, Bisphosphonate Induced
Bisphosphonate-Associated Osteonecrosis- Bisphosphonate-Associated Osteonecrosis
- Bisphosphonate Associated Osteonecrosis
- Bisphosphonate-Associated Osteonecroses
- Osteonecroses, Bisphosphonate-Associated
- Osteonecrosis, Bisphosphonate-Associated
- Bisphosphonate Osteonecrosis
- Bisphosphonate Osteonecroses
- Osteonecroses, Bisphosphonate
- Osteonecrosis, Bisphosphonate
|
Below are MeSH descriptors whose meaning is more general than "Bisphosphonate-Associated Osteonecrosis of the Jaw".
Below are MeSH descriptors whose meaning is more specific than "Bisphosphonate-Associated Osteonecrosis of the Jaw".
This graph shows the total number of publications written about "Bisphosphonate-Associated Osteonecrosis of the Jaw" by people in this website by year, and whether "Bisphosphonate-Associated Osteonecrosis of the Jaw" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 1 | 0 | 1 |
2013 | 1 | 1 | 2 |
2014 | 2 | 0 | 2 |
2015 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bisphosphonate-Associated Osteonecrosis of the Jaw" by people in Profiles.
-
Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis. Support Care Cancer. 2021 May; 29(5):2305-2317.
-
Skeletal Site-Specific Response of Jawbones and Long Bones to Surgical Interventions in Rats Treated with Zoledronic Acid. Biomed Res Int. 2019; 2019:5138175.
-
A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer. Support Care Cancer. 2018 Jun; 26(6):1905-1915.
-
Benefits and potential risks of bisphosphonate therapy A narrative review. J Med Liban. 2016 Oct-Dec; 64(4):228-37.
-
Impact of bone-targeted therapies in chemotherapy-na?ve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302. Eur Urol. 2015 Oct; 68(4):570-7.
-
Complications of new medications. West J Emerg Med. 2015 Jan; 16(1):154-6.
-
The role of bisphosphonates in medical oncology and their association with jaw bone necrosis. Oral Maxillofac Surg Clin North Am. 2014 May; 26(2):231-7.
-
Mandibulectomy and free flap reconstruction for bisphosphonate-related osteonecrosis of the jaws. JAMA Otolaryngol Head Neck Surg. 2013 Nov; 139(11):1135-42.
-
Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-?B ligand inhibitors in patients with advanced prostate cancer. Eur Urol. 2014 Feb; 65(2):278-86.
-
Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc. 2011 Nov; 142(11):1243-51.